Global Immunotherapy with Oncolytic Viruses and mRNA Vaccines & Therapeutics Report Package 2017 – Research … – Business Wire (press release)
|
Global Immunotherapy with Oncolytic Viruses and mRNA Vaccines & Therapeutics Report Package 2017 – Research …
Business Wire (press release) mRNA is a rather versatile therapeutic modality and offers a range of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for … |
